Innovation1 Biotech Net Income
| IVBT Stock | USD 0.0002 0.00 0.00% |
Innovation1 Biotech technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We have analyzed zero technical drivers for Innovation1 Biotech, which can be compared to its competitors.
Analyzing historical trends in various income statement and balance sheet accounts from Innovation1 Biotech's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Innovation1 Biotech's valuation are summarized below:Innovation1 Biotech does not presently have any fundamental trends for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Innovation1 |
Innovation1 Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Innovation1 Biotech's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Innovation1 Biotech.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Innovation1 Biotech on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Innovation1 Biotech or generate 0.0% return on investment in Innovation1 Biotech over 90 days. Innovation1 Biotech Inc. operates as a small molecule drug discovery company More
Innovation1 Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Innovation1 Biotech's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Innovation1 Biotech upside and downside potential and time the market with a certain degree of confidence.
Innovation1 Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Innovation1 Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Innovation1 Biotech's standard deviation. In reality, there are many statistical measures that can use Innovation1 Biotech historical prices to predict the future Innovation1 Biotech's volatility.Innovation1 Biotech Backtested Returns
We have found three technical indicators for Innovation1 Biotech, which you can use to evaluate the volatility of the firm. The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Innovation1 Biotech are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Innovation1 Biotech has perfect predictability. Overlapping area represents the amount of predictability between Innovation1 Biotech time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Innovation1 Biotech price movement. The serial correlation of 1.0 indicates that 100.0% of current Innovation1 Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Innovation1 Biotech reported net income of (40.88 Million). This is 111.98% lower than that of the Healthcare sector and 158.36% lower than that of the Biotechnology industry. The net income for all United States stocks is 107.16% higher than that of the company.
Innovation1 Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Innovation1 Biotech's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Innovation1 Biotech could also be used in its relative valuation, which is a method of valuing Innovation1 Biotech by comparing valuation metrics of similar companies.Innovation1 Biotech is currently under evaluation in net income category among its peers.
Innovation1 Fundamentals
| Return On Equity | -1.79 | |||
| Return On Asset | -0.0781 | |||
| Current Valuation | 1.83 M | |||
| Shares Outstanding | 20.02 M | |||
| Shares Owned By Insiders | 74.66 % | |||
| Price To Earning | 0.01 X | |||
| Price To Book | 0.05 X | |||
| Gross Profit | (17 K) | |||
| EBITDA | (38.33 M) | |||
| Net Income | (40.88 M) | |||
| Cash And Equivalents | 636.16 K | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 554.4 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 0.03 X | |||
| Book Value Per Share | 0.10 X | |||
| Cash Flow From Operations | (3.13 M) | |||
| Earnings Per Share | 5.54 X | |||
| Beta | 5.08 | |||
| Market Capitalization | 4.5 M | |||
| Total Asset | 43.96 M | |||
| Z Score | 4.8 | |||
| Net Asset | 43.96 M |
About Innovation1 Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Innovation1 Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Innovation1 Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Innovation1 Biotech based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Innovation1 OTC Stock Analysis
When running Innovation1 Biotech's price analysis, check to measure Innovation1 Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovation1 Biotech is operating at the current time. Most of Innovation1 Biotech's value examination focuses on studying past and present price action to predict the probability of Innovation1 Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovation1 Biotech's price. Additionally, you may evaluate how the addition of Innovation1 Biotech to your portfolios can decrease your overall portfolio volatility.